BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34237703)

  • 1. Identification of KMT2A-ARHGEF12 fusion in a child with a high-grade B-cell lymphoma.
    Schafernak KT; Williams JA; Clyde BI; Marcus C; Decker B; Toydemir RM
    Cancer Genet; 2021 Nov; 258-259():23-26. PubMed ID: 34237703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel KMT2A-ARHGEF12 Fusion Gene Identified in a High-Grade B-cell Lymphoma.
    Jung HS; Lin F; Wolpaw A; Reilly AF; Margolskee E; Luo M; Wertheim GB; Li MM
    Cancer Genet; 2020 Aug; 246-247():41-43. PubMed ID: 32805689
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy-induced Deletion in 11q23 Leading to Fusion of
    Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
    Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First case of B ALL with KMT2A-MAML2 rearrangement: a case report.
    Menu E; Beaufils N; Usseglio F; Balducci E; Lafage Pochitaloff M; Costello R; Gabert J
    BMC Cancer; 2017 May; 17(1):363. PubMed ID: 28535805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
    Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
    Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel KMT2A/GIMAP8 gene fusion in a pediatric patient with acute undifferentiated leukemia.
    Berg HE; Blackburn PR; Baughn LB; Ketterling RP; Xu X; Greipp PT; Hoppman NL; Smadbeck JB; Vasmatzis G; Shi M; Reichard KK; Viswanatha DS; Jevremovic D; Maher GM; Peterson JF
    Genes Chromosomes Cancer; 2021 Feb; 60(2):108-111. PubMed ID: 33078871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemia.
    Ferrari A; Ghelli Luserna Di Rora A; Domizio C; Papayannidis C; Simonetti G; Maria Hernández-Rivas J; Rondoni M; Giglio F; Abruzzese E; Imovilli A; Iacobucci I; Calistri D; Martinelli G
    Br J Haematol; 2021 Mar; 192(6):e139-e144. PubMed ID: 33314053
    [No Abstract]   [Full Text] [Related]  

  • 8. First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia.
    Tandon S; Shago M; Davidson S; Kanwar N; Fuligni F; Shlien A; Whitlock J; Villani A; Abla O
    Cancer Genet; 2020 Oct; 248-249():31-33. PubMed ID: 32992102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
    Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.
    Pincez T; Landry JR; Roussy M; Jouan L; Bilodeau M; Laramée L; Couture F; Sinnett D; Gendron P; Hébert J; Oligny L; Rouette A; Tran TH; Wilhelm BT; Bittencourt H; Cellot S
    Genes Chromosomes Cancer; 2020 Feb; 59(2):125-130. PubMed ID: 31515871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KMT2A-ARHGEF12, a therapy related fusion with poor prognosis.
    Assaf N; Liévin R; Merabet F; Raggueneau V; Osman J; Kim R; Garnache F; D'Angiò M; Larghero P; Meyer C; Marschalek R; Rousselot P; Terré C
    Mol Biol Rep; 2021 Oct; 48(10):7021-7027. PubMed ID: 34383244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
    Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
    Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of
    Forlenza CJ; Zhang Y; Yao J; Benayed R; Steinherz P; Ramaswamy K; Kessel R; Roshal M; Shukla N
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30455225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
    Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
    Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel KMT2A-ACTN2 fusion in infant B-cell acute lymphoblastic leukemia.
    Yoshida M; Nakabayashi K; Ogata-Kawata H; Osumi T; Tsujimoto SI; Shirai R; Yoshida K; Okamura K; Matsumoto K; Kiyokawa N; Tomizawa D; Hata K; Kato M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27821. PubMed ID: 31115144
    [No Abstract]   [Full Text] [Related]  

  • 16. The KMT2A recombinome of acute leukemias in 2023.
    Meyer C; Larghero P; Almeida Lopes B; Burmeister T; Gröger D; Sutton R; Venn NC; Cazzaniga G; Corral Abascal L; Tsaur G; Fechina L; Emerenciano M; Pombo-de-Oliveira MS; Lund-Aho T; Lundán T; Montonen M; Juvonen V; Zuna J; Trka J; Ballerini P; Lapillonne H; Van der Velden VHJ; Sonneveld E; Delabesse E; de Matos RRC; Silva MLM; Bomken S; Katsibardi K; Keernik M; Grardel N; Mason J; Price R; Kim J; Eckert C; Lo Nigro L; Bueno C; Menendez P; Zur Stadt U; Gameiro P; Sedék L; Szczepański T; Bidet A; Marcu V; Shichrur K; Izraeli S; Madsen HO; Schäfer BW; Kubetzko S; Kim R; Clappier E; Trautmann H; Brüggemann M; Archer P; Hancock J; Alten J; Möricke A; Stanulla M; Lentes J; Bergmann AK; Strehl S; Köhrer S; Nebral K; Dworzak MN; Haas OA; Arfeuille C; Caye-Eude A; Cavé H; Marschalek R
    Leukemia; 2023 May; 37(5):988-1005. PubMed ID: 37019990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
    Zerkalenkova E; Lebedeva S; Kazakova A; Tsaur G; Starichkova Y; Timofeeva N; Soldatkina O; Aprelova E; Popov A; Ponomareva N; Baidun L; Meyer C; Novichkova G; Maschan M; Maschan A; Marschalek R; Olshanskaya Y
    Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of KMT2A-MLLT3 fusion-positive mature B-cell acute lymphoblastic leukemia.
    Mitani Y; Arakawa Y; Mori M; Deguchi T; Koh K
    Pediatr Int; 2021 Jun; 63(6):719-722. PubMed ID: 33871895
    [No Abstract]   [Full Text] [Related]  

  • 19. Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next-generation sequencing and dual-fusion FISH analysis.
    Raghunandan S; Jain J; Saxe D; Pauly M; Aljudi AA; Ketterling RP; Carter AB; Raikar SS
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29428. PubMed ID: 34766724
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
    Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.